Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Eli Lilly and Company    LLY

ELI LILLY AND COMPANY

(LLY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Eli Lilly and : Lilly Confirms Date and Conference Call for Fourth-Quarter 2019 Financial Results Announcement

share with twitter share with LinkedIn share with facebook
share via e-mail
01/16/2020 | 03:46pm EST

INDIANAPOLIS, Jan. 16, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its fourth-quarter and full-year 2019 financial results on Thursday, January 30, 2020. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will begin at 9 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations. A replay will also be available on the website following the conference call.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com.  F-LLY   

Refer to:
Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)   
Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)        

Eli Lilly and Company logo. (PRNewsfoto/Eli Lilly and Company)

 

Cision
View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-fourth-quarter-2019-financial-results-announcement-300988567.html

SOURCE Eli Lilly and Company


© PRNewswire 2020
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ELI LILLY AND COMPANY
02/21ELI LILLY AND : Trulicity® (dulaglutide) is the first and only type 2 diabetes m..
PR
02/21ELI LILLY AND : Lilly to Participate in Cowen Health Care Conference
PR
02/21ELI LILLY AND : Lilly To Participate in SVB Leerink Global Healthcare Conference
PR
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/20EXCLUSIVE : Canadian regulator considers changes to new drug pricing plan
RE
02/19ELI LILLY AND : & CO Management's Discussion and Analysis of Results of Operatio..
AQ
02/19ELI LILLY AND : Backed Terns Reports Positive Phase 1 Results for TERN-101 in NA..
DJ
02/13ELI LILLY AND COMPANY : Ex-dividend day for
FA
02/11ELI LILLY AND : Lilly Announces Topline Results for Solanezumab from the Dominan..
AQ
02/11EAGLE PHARMACEUTICALS : Receives final fda approval for pemfexy
AQ
More news